Lca-Vision Inc (LCAV) 5.37 $LCAV
LCA-Vision Has Returned 38.9% Since SmarTrend Recommendation (LCAV)
Comtex SmarTrend(R) - Thu May 08, 10:59AM CDT
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 9 months, LCA-Vision has returned 38.94% as of today's recent price of $5.37.
Shares of LCAV Up 38.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 01, 9:37AM CDT
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 9 months, LCA-Vision has returned 38.68% as of today's recent price of $5.36.
LCA-Vision Reports First Quarter Financial Results
PR Newswire - Wed Apr 30, 6:00AM CDT
LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three months ended March 31, 2014.
LCA-Vision Announces ISS and Glass, Lewis Recommend Stockholders Vote in Favor of $5.37 per share Cash Acquisition by PhotoMedex
PR Newswire - Wed Apr 23, 3:52PM CDT
LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today announced that two leading proxy advisory firms, ISS Proxy Advisory Services and Glass, Lewis & Co., has each issued a recommendation that LCA-Vision Inc. stockholders vote in favor of all proposals related to its acquisition by PhotoMedex, Inc. for $5.37 per share in cash at its Special Meeting of Stockholders scheduled to be held on May 7, 2014.
38.4% Return Seen to Date on SmarTrend LCA-Vision Call (LCAV)
Comtex SmarTrend(R) - Wed Apr 16, 4:42PM CDT
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 9 months, LCA-Vision has returned 38.42% as of today's recent price of $5.35.
LCA-Vision Up 38.4% Since SmarTrend Uptrend Call (LCAV)
Comtex SmarTrend(R) - Wed Apr 02, 9:38AM CDT
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 8 months, LCA-Vision has returned 38.42% as of today's recent price of $5.35.
LCA-Vision Reports First Quarter Procedure Volume of 14,898
PR Newswire - Wed Apr 02, 6:00AM CDT
LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 14,898 procedures were performed during the first quarter of 2014, a decline of 8% from the 16,272 procedures performed during the first quarter of 2013.
Humana's Ratings Affirmed by A.M. Best - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 5:40PM CST
Credit rating agency A. M. Best Co. has affirmed some ratings of Humana Inc.
WellPoint, American Academy of Pediatrics Pen Deal (revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 2:29PM CST
Per the alliance, the American Academy of Pediatrics and WellPoint will chalk out a series that will educate physicians -- specifically designed for pediatricians -- on pediatric health issues like childhood obesity, asthma and behavioral concerns.
WellPoint, American Academy of Pediatrics Pen Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 5:00PM CST
WellPoint Inc. (WLP) has been working toward increasing awareness among the masses about child health. For this, the company has collaborated with The American Academy of Pediatrics.
Tenet Arm, University Health Pen Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 3:55PM CST
Tenet Healthcare subsidiary Conifer Health Solutions has inked a deal with University Health System.
Chemed Corp. (CHE) Surges: Why It Still Has Room to Run? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:45AM CST
Chemed Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy
Uptrend Call Working As LCA-Vision Stock Rises 41.3% (LCAV)
Comtex SmarTrend(R) - Tue Feb 25, 9:10AM CST
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 7 months, LCA-Vision has returned 41.27% as of today's recent price of $5.46.
Brower Piven Announces Class Action Lawsuit in Connection With Claims of Breaches of Fiduciary Duty by the Board of Directors of LCA-Vision, Inc. in Connection With the Sale of the Company to PhotoMedex, Inc. -- LCAV
GlobeNewswire - Fri Feb 21, 1:13PM CST
The securities litigation firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in Delaware state court on behalf of all common stockholders of LCA-Vision, Inc. ("LCA" or the "Company"
(Nasdaq:LCAV).
LCA-Vision Has Returned 38.9% Since SmarTrend Recommendation (LCAV)
Comtex SmarTrend(R) - Thu May 08, 10:59AM CDT
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 9 months, LCA-Vision has returned 38.94% as of today's recent price of $5.37.
Shares of LCAV Up 38.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 01, 9:37AM CDT
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 9 months, LCA-Vision has returned 38.68% as of today's recent price of $5.36.
LCA-Vision Reports First Quarter Financial Results
PR Newswire - Wed Apr 30, 6:00AM CDT
LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three months ended March 31, 2014.
LCA-Vision Announces ISS and Glass, Lewis Recommend Stockholders Vote in Favor of $5.37 per share Cash Acquisition by PhotoMedex
PR Newswire - Wed Apr 23, 3:52PM CDT
LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today announced that two leading proxy advisory firms, ISS Proxy Advisory Services and Glass, Lewis & Co., has each issued a recommendation that LCA-Vision Inc. stockholders vote in favor of all proposals related to its acquisition by PhotoMedex, Inc. for $5.37 per share in cash at its Special Meeting of Stockholders scheduled to be held on May 7, 2014.
38.4% Return Seen to Date on SmarTrend LCA-Vision Call (LCAV)
Comtex SmarTrend(R) - Wed Apr 16, 4:42PM CDT
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 9 months, LCA-Vision has returned 38.42% as of today's recent price of $5.35.
LCA-Vision Up 38.4% Since SmarTrend Uptrend Call (LCAV)
Comtex SmarTrend(R) - Wed Apr 02, 9:38AM CDT
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 8 months, LCA-Vision has returned 38.42% as of today's recent price of $5.35.
LCA-Vision Reports First Quarter Procedure Volume of 14,898
PR Newswire - Wed Apr 02, 6:00AM CDT
LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 14,898 procedures were performed during the first quarter of 2014, a decline of 8% from the 16,272 procedures performed during the first quarter of 2013.
Humana's Ratings Affirmed by A.M. Best - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 5:40PM CST
Credit rating agency A. M. Best Co. has affirmed some ratings of Humana Inc.
WellPoint, American Academy of Pediatrics Pen Deal (revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 2:29PM CST
Per the alliance, the American Academy of Pediatrics and WellPoint will chalk out a series that will educate physicians -- specifically designed for pediatricians -- on pediatric health issues like childhood obesity, asthma and behavioral concerns.
WellPoint, American Academy of Pediatrics Pen Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 5:00PM CST
WellPoint Inc. (WLP) has been working toward increasing awareness among the masses about child health. For this, the company has collaborated with The American Academy of Pediatrics.
Tenet Arm, University Health Pen Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 3:55PM CST
Tenet Healthcare subsidiary Conifer Health Solutions has inked a deal with University Health System.
Chemed Corp. (CHE) Surges: Why It Still Has Room to Run? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:45AM CST
Chemed Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy
Uptrend Call Working As LCA-Vision Stock Rises 41.3% (LCAV)
Comtex SmarTrend(R) - Tue Feb 25, 9:10AM CST
SmarTrend identified an Uptrend for LCA-Vision (NASDAQ:LCAV) on July 31st, 2013 at $3.87. In approximately 7 months, LCA-Vision has returned 41.27% as of today's recent price of $5.46.
Brower Piven Announces Class Action Lawsuit in Connection With Claims of Breaches of Fiduciary Duty by the Board of Directors of LCA-Vision, Inc. in Connection With the Sale of the Company to PhotoMedex, Inc. -- LCAV
GlobeNewswire - Fri Feb 21, 1:13PM CST
The securities litigation firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in Delaware state court on behalf of all common stockholders of LCA-Vision, Inc. ("LCA" or the "Company"
(Nasdaq:LCAV). 
